Top compounds associated with response to KLC3


Feature Type Standardized
Nominal ANOVA
mRNA etoposide GDSC1000 pan-cancer AAC 0.057 0.2
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.051 0.2
mRNA AC220 GDSC1000 pan-cancer AAC -0.055 0.2
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.058 0.2
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.056 0.2
mRNA YM201636 GDSC1000 pan-cancer AAC -0.049 0.2
mRNA PRL-3 Inhibitor I CTRPv2 pan-cancer AAC -0.058 0.2
mRNA FTI-277 GDSC1000 pan-cancer AAC 0.054 0.2
mRNA BRD-M00053801 CTRPv2 pan-cancer AAC -0.076 0.2
mRNA BMS-270394 CTRPv2 pan-cancer AAC -0.056 0.2
Download CSV